Ex-Jones Day boss: Healthcare venture capital is actually great, thank you very much
And don't expect family offices to take the place of venture capital.
Is venture capital bad for life sciences? 3 reasons why (and what should replace it)
Impact financing, venture philanthropy and a new breed of investors, says MIT's Andrew Lo.
Why Pharma Companies Should Look To Social Media For Better Patient Insight
Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction.